Background and Objectives: Cervical cancer is a leading cause of cancer death in female populations. It is a virally induced carcinoma resulting from sexually transmitted high risk Human Papillomavirus infections (e.g. HPV-16, HPV-18). Previous studies have shown associations between IL-17A levels in cancer micro-environments and metastasis of tumor cells. In Africa, chemotherapy (CT) is the standard first-line treatment for cervical cancer and the prognosis remains poor for metastatic and recurrent cases. The impact of CT as a treatment option is still unclear. We investigated the prognostic relevance of IL-17A profiles in Cervical cancer patients (CP) patients treated with cisplatin in combination with 5-fluouracil (5FU) for three cycles. Methods: The study included 57 CP and 59 women with no history of malignancy as healthy controls (HC). IL-17A plasma levels were evaluated by ELISA. For each CP, three blood samples were collected at three-week intervals before initiation of the chemotherapy protocol. Results: Before chemotherapy CP showed higher serum levels of IL-17A compared to HCs (p = 0.035). No relation was detected between age and IL-17A levels. We observed a significant increase in serum IL-17A during treatment of the CP group (p < 0.05). Depending on chemotherapy’s efficacy, CP were divided into 1) non responders, 2) partial responders and 3) good responders. Non-responders patients showed significantly higher serum levels of IL-17A during the follow-up compared to partial and good responder groups both following the first CT cycle (p < 0.05) and the second CT cycle (p < 0.03). Conclusion: Our results suggest that high serum levels of IL-17A are associated with poor responses to classical chemotherapy. However, considering these results to design CC biomarkers, we need further investigations particularly about the relevant prognostic indicator following chemotherapy.
Siegel, R.L., Miller, K.D. and Jemal, A. (2017) Cancer Statistics, 2017. CA: A Cancer Journal for Clinicians, 67, 7-30. https://doi.org/10.3322/caac.21387
Schiffman, M.H. and Brinton, L.A. (1995) The Epidemiology of Cervical Carcinogenesis. Cancer, 76, 1888-1901. https://doi.org/10.1002/1097-0142(19951115)76:10+ 3.0.CO;2-H
Ferlay, J., Soerjomataram, I., Ervik, M., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D., Forman, D. and Bray, F. (2013) Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11.
Shankaran, V., Ikeda, H., Bruce, A.T., White, J.M., Swanson, P.E., Old, L.J. and Schreiber, R.D. (2001) IFNgamma and Lymphocytes Prevent Primary Tumour Development and Shape Tumour Immunogenicity. Nature, 410, 1107-1111. https://doi.org/10.1038/35074122
Marzo, A.L., Kinnear, B.F., Lake, R.A., Frelinger, J.J., Collins, E.J., Robinson, B.W.S. and Scott, B. (2000) Tumor-Specific CD4+ T Cells Have a Major “Post-Licensing” Role in CTL Mediated Anti-Tumor Immunity. The Journal of Immunology, 165, 6047-6055. https://doi.org/10.4049/jimmunol.165.11.6047
Street, S.E., Cretney, E. and Smyth, M.J. (2001) Perforin and Interferon-Gamma Activities Independently Control Tumor Initiation, Growth, and Metastasis. Blood, 97, 192-197. https://doi.org/10.1182/blood.V97.1.192
Street, S.E., Trapani, J.A., MacGregor, D. and Smyth, M.J. (2002) Suppression of Lymphoma and Epithelial Malignancies Effected by IFN Gamma. Journal of Experimental Medicine, 196, 129-134. https://doi.org/10.1084/jem.20020063
Kolls, J.K. and Linden, A. (2004) Interleukin-17 Family Members and Inflammation. Immunity, 21, 467-476. https://doi.org/10.1016/j.immuni.2004.08.018
Zou, W. and Restifo, N.P. (2010) TH17 Cells in Tumour Immunity and Immunotherapy. Nature Reviews Immunology, 10, 248-256. https://doi.org/10.1038/nri2742
Souza, J.M., Matias, B.F., Rodrigues, C.M., Murta, E.F. and Michelin, M.A. (2013) IL-17 and IL-22 Serum Cytokine Levels in Patients with Squamous Intraepithelial Lesion and Invasive Cervical Carcinoma. European Journal of Gynaecological Oncology, 34, 466-468.
Cua, D.J. and Tato, C.M. (2010) Innate IL-17-Producing Cells: The Sentinels of the Immune System. Nature Reviews Immunology, 10, 479-489. https://doi.org/10.1038/nri2800
Pelletier, M., Maggi, L., Micheletti, A., Lazzeri, E., Tamassia, N., Costantini, C., Cosmi, L., Lunardi, C., Annunziato, F., Romagnani, S. and Cassatella, M.A. (2010) Evidence for a Cross-Talk between Human Neutrophils and Th17 Cells. Blood, 115, 335-343. https://doi.org/10.1182/blood-2009-04-216085
Marchetti, C., De Felice, F., Di Pinto, A., Romito, A., Musella, A., Palaia, I., Monti, M., Tombolin, V., Muzii, L. and Benedetti Panici, P. (2018) Survival Nomograms after Curative Neoadjuvant Chemotherapy and Radical Surgery for Stage IB2-IIIB Cervical Cancer. Cancer Research and Treatment, 50, 768-776. https://doi.org/10.4143/crt.2017.141
Mallmann, P. (2016) A Change of Paradigm in the Treatment of Cervical Cancer. Oncology Research and Treatment, 39, 500. https://doi.org/10.1159/000448967
Waggoner, S.E. (2003) Cervical Cancer. The Lancet, 361, 2217-2225. https://doi.org/10.1016/S0140-6736(03)13778-6
Ndiaye, R., Dem, A., Mbaye, P.M., Guèye, P.M., Diop, G., Diop, P.A. and Faye, O. (2014) étude du codon 72 du gène p53 dans la prédisposition au cancer du col de l’utérus au Sénégal. Bulletin du Cancer, 101, 789-794.
Dem, A., Dieng, M.M., Traore, B., Gaye, M., Diop, M. and Touré, P. (2008) Les carcinomes épidermoides du col utérin à l’Institut du cancer de Dakar. Cahiers d’études et de recherches francophones/Santé, 18, 31-33. https://doi.org/10.1684/san.2008.0094
Zhu, X., Mulcahy, L.A., Mohammed, R.A., Lee, A.H., Franks, H.A., Kilpatrick, L., Yilmazer, A., Paish, E.C., Ellis, I.O., Patel, P.M. and Jackson, A.M. (2008) IL-17 Expression by Breast-Cancer-Associated Macrophages: IL-17 Promotes Invasiveness of Breast Cancer Cell Lines. Breast Cancer Research, 10, R95. https://doi.org/10.1186/bcr2195
Fujino, S., Andoh, A., Bamba, S., Ogawa, A., Hata, K., Araki, Y., Bamba, T. and Fujiyama, Y. (2003) Increased Expression of Interleukin 17 in Inflammatory Bowel Disease. Gut, 52, 65-70. https://doi.org/10.1136/gut.52.1.65
Li, Q., Chen, J., Liu, Y., Zhao, X., Tan, B., Ai, J., Zhang, Z., Song, J. and Shan, B. (2013) Prevalence of Th17 and Treg Cells in Gastric Cancer Patients and Its Correlation with Clinical Parameters. Oncology Reports, 30, 1215-1222. https://doi.org/10.3892/or.2013.2570
Zhang, J.P., Yan, J., Xu, J., Pang, X.H., Chen, M.S., Li, L., Wu, C., Li, S.P. and Zheng, L. (2009) Increased Intratumoral IL-17-Producing Cells Correlate with Poor Survival in Hepatocellular Carcinoma Patients. Journal of Hepatology, 50, 980-989. https://doi.org/10.1016/j.jhep.2008.12.033
Kato, T., Furumoto, H., Ogura, T., Onishi, Y., Irahara, M., Yamano, S., Kamada, M. and Aono, T. (2001) Expression of IL-17 mRNA in Ovarian Cancer. Biochemical and Biophysical Research Communications, 282, 735-738. https://doi.org/10.1006/bbrc.2001.4618
Lyon, D.E., McCain, N.L., Walter, J. and Schubert, C. (2008) Cytokine Comparisons between Women with Breast Cancer and Women with a Negative Breast Biopsy. Nursing Research, 57, 51-58. https://doi.org/10.1097/01.NNR.0000280655.58266.6c
Bettelli, E., Korn, T., Oukka, M. and Kuchroo, V.K. (2008) Induction and Effector Functions of TH17 Cells. Nature, 453, 1051-1057. https://doi.org/10.1038/nature07036
Nam, J.S., Terabe, M., Kang, M.J., Chae, H., Voong, N., Yang, Y.A., Laurence, A., Michalowska, A., Mamura, M., Lonning, S., Berzofsky, J.A. and Wakefield, L.M. (2008) Transforming Growth Factor Beta Subverts the Immune System into Directly Promoting Tumor Growth through Interleukin-17. Cancer Research, 68, 3915-3923. https://doi.org/10.1158/0008-5472.CAN-08-0206
Kryczek, I., Wei, S., Zou, L., Altuwaijri, S., Szeliga, W., Kolls, J., Chang, A. and Zou, W. (2007) Cutting Edge: Th17 and Regulatory T Cell Dynamics and the Regulation by IL-2 in the Tumor Microenvironment. The Journal of Immunology, 178, 6730-6733. https://doi.org/10.4049/jimmunol.178.11.6730
Becht, E., Giraldo, N.A., Dieu-Nosjean, M.C., Sautes-Fridman, C. and Fridman, W.H. (2016) Cancer Immune Contexture and Immunotherapy. Current Opinion in Immunology, 39, 7-13. https://doi.org/10.1016/j.coi.2015.11.009
Numasaki, M., Fukushi, J., Ono, M., Narula, S.K., Zavodny, P.J., Kudo, T., Robbins, P.D., Tahara, H. and Lotze, M.T. (2003) Interleukin-17 Promotes Angiogenesis and Tumor Growth. Blood, 101, 2620-2627. https://doi.org/10.1182/blood-2002-05-1461